Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia

Journal of Clinical Pharmacy and Therapeutics

Volumn 41, Issue 6, 2016, Pages 657-661

  Shi, D D ^a   Yang, F Z ^a   Zhou, L ^a   Wang, N ^a  

^a CANGZHOU CENTRAL HOSPITAL   (China)

Author keywords

labetalol; nifedipine; pre eclampsia; pregnancy

Indexed keywords

LABETALOL; NIFEDIPINE; ANTIHYPERTENSIVE AGENT;

ADULT; ADVERSE OUTCOME; ARTICLE; BLOOD PRESSURE REGULATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PREECLAMPSIA; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; TREATMENT OUTCOME; VOMITING; BLOOD PRESSURE; DRUG EFFECTS; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LABETALOL; NIFEDIPINE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 84992168536     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12439     Document Type: Article

References (28)

1. Bijvank SW, Visser W, Duvekot JJ et al. Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial. Eur J Obstet Gynecol Reprod Biol, 2015;189:106–111.
2. Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev, 2014;2:CD002252.
3. Magee LA, Helewa M, Moutquin JM, von Dadelszen P. Hypertension Guideline C, Strategic Training Initiative in Research in the Reproductive Health Sciences S. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can, 2008;30:S1–S48.
4. Duley L. Pre-eclampsia, eclampsia, and hypertension. BMJ Clin Evid, 2008;2008:1402.
5. Belfort MA, Anthony J, Buccimazza A, Davey DA. Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension. Obstet Gynecol, 1990;75:970–974.
6. Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev, 2013;7:CD001449.
7. Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol, 1991;77:331–337.
8. Giannubilo SR, Bezzeccheri V, Cecchi S et al. Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy. Arch Gynecol Obstet, 2012;286:637–642.
9. Childress CH, Katz VL. Nifedipine and its indications in obstetrics and gynecology. Obstet Gynecol, 1994;83:616–624.
10. Ferlinz J. Nifedipine in myocardial ischemia, systemic hypertension, and other cardiovascular disorders. Ann Intern Med, 1986;105:714–729.
11. Barton JR, Hiett AK, Conover WB. The use of nifedipine during the postpartum period in patients with severe preeclampsia. Am J Obstet Gynecol, 1990;162:788–792.
12. Clark SM, Dunn HE, Hankins GD. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy. Semin Perinatol, 2015;39:548–555.
13. Magee LA. Treating hypertension in women of child-bearing age and during pregnancy. Drug Saf, 2001;24:457–474.
14. Magee LA, Abalos E, von Dadelszen P et al. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol, 2011;72:394–401.
15. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev, 2007;CD002252.
16. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA, 2003;289:2560–2572.
17. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev, 2006;CD001449.
18. Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG, 2012;119:78–85.
19. Shi Q, Leng W, Yao Q, Mi C, Xing A. Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy. Int J Cardiol, 2015;178:162–164.
20. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ, 2003;327:955–960.
21. Aali BS, Nejad SS. Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia. Acta Obstet Gynecol Scand, 2002;81:25–30.
22. Remuzzi G, Ruggenenti P. Prevention and treatment of pregnancy-associated hypertension: what have we learned in the last 10 years? Am J Kidney Dis, 1991;18:285–305.
23. Brown MA, Hague WM, Higgins J et al. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol, 2000;40:139–155.
24. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ, 1997;157:1245–1254.
25. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol, 2003;102:181–192.
26. Delgado De Pasquale S, Velarde R, Reyes O, De La Ossa K. Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial. Pregnancy Hypertens, 2014;4:19–22.
27. Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol, 1999;181:858–861.
28. Shekhar S, Gupta N, Kirubakaran R, Pareek P. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. BJOG, 2016;123:40–47.